A prenatal treatment raises questions of medical ethics (TIME Magazine, 18 June 2010)

SfE Autumn Endocrine Retreat - Registration extended!

UK's NICE backs Amgen bone drug for some women (Reuters, 18 June 2010)

18 Jun 2010

The National Institute for Health and Clinical Excellence (NICE) has issued a statement on the use of the newly-approved drug Denosumab in the treatment of osteoporosis in post-menopausal women, recommending its use where bisphosphonates are unsuitable.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read